Lonza is a global leader in contract development and manufacturing services with strong R&D capabilities, and world class facilities in more than 30 countries. In 2019, Lonza supported more than 730 preclinical and clinical small and large molecules, more than 310 commercial small and large molecules and produced more than 200 billion capsules.

  • Nominated in 2020

  • Winner in 2021